• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国家药物警戒系统介绍。

Introducing the National Drug Early Warning System.

机构信息

Center for Substance Abuse Research (CESAR), University of Maryland, College Park, Maryland, USA.

出版信息

Curr Opin Psychiatry. 2020 Jul;33(4):319-325. doi: 10.1097/YCO.0000000000000610.

DOI:10.1097/YCO.0000000000000610
PMID:32250985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7386464/
Abstract

PURPOSE OF REVIEW

In 2013, NIH NIDA released a special funding opportunity to update and expand their longstanding Community Epidemiology Workgroup (CEWG) by creating a coordinating center for a new type of monitoring system that became the National Drug Early Warning System (NDEWS). This article provides an overview of four primary NDEWS components: core staff; an approach to detecting and monitoring emerging drug trends including community-based epidemiologists and national databases; small rapid follow-up studies; and innovative multimedia approaches for disseminating information.

RECENT FINDINGS

The cornerstones for detecting and monitoring are the 1700+ member NDEWS Network and a coalition of local epidemiologists. Follow-up studies are designed with local researchers, practitioners, and policymakers to focus on local trends. Among NDEWS accomplishments are developing protocols for expanded urinalyses in high-risk populations and conducting follow-up studies with local collaborators in New Hampshire, New York, Ohio, Oregon, and a tribal nation in Minnesota.

SUMMARY

During its first 6 years, NDEWS has advanced its mission to develop multidisciplinary collaborations and innovative technologies for identifying, monitoring, and following up on emerging drug trends and has contributed to the translation of science into practice. VIDEO ABSTRACT: http://links.lww.com/YCO/A55.

摘要

综述目的:2013 年,NIH 国家药物滥用研究所(NIDA)发布了一项特别资助机会,通过创建一个协调中心来更新和扩展其长期存在的社区流行病学工作组(CEWG),以创建一种新型监测系统,即国家药物预警系统(NDEWS)。本文概述了 NDEWS 的四个主要组成部分:核心人员;一种用于检测和监测新兴药物趋势的方法,包括基于社区的流行病学家和国家数据库;小型快速后续研究;以及用于传播信息的创新多媒体方法。

最新发现:检测和监测的基石是由 1700 多名成员组成的 NDEWS 网络和一个由当地流行病学家组成的联盟。后续研究是与当地研究人员、从业者和政策制定者合作设计的,重点关注当地趋势。NDEWS 的成就包括为高危人群制定扩展尿液分析的方案,并与新罕布什尔州、纽约州、俄亥俄州、俄勒冈州和明尼苏达州的一个部落国家的当地合作者进行后续研究。

总结:在成立的头 6 年里,NDEWS 推进了其使命,即开发多学科合作和创新技术,以识别、监测和跟踪新兴药物趋势,并为将科学转化为实践做出了贡献。

相似文献

1
Introducing the National Drug Early Warning System.国家药物警戒系统介绍。
Curr Opin Psychiatry. 2020 Jul;33(4):319-325. doi: 10.1097/YCO.0000000000000610.
2
Toward a National System of Expanded Testing of Existing Urine Specimens: The Drug Outbreak Testing Service (DOTS).建立全国范围的现有尿液样本扩展检测系统:药物爆发检测服务(DOTS)。
Subst Use Misuse. 2021;56(11):1576-1585. doi: 10.1080/10826084.2021.1928213. Epub 2021 Jul 19.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.在社区开展的研究方案的质量保证:美国国立药物滥用研究所临床试验网络的经验。
Clin Trials. 2009 Apr;6(2):151-61. doi: 10.1177/1740774509102560.
5
Co-use of methamphetamine and opioids among people in treatment in Oregon: A qualitative examination of interrelated structural, community, and individual-level factors.在俄勒冈州接受治疗的人群中,冰毒和阿片类药物的共同使用:对相关结构、社区和个体层面因素的定性研究。
Int J Drug Policy. 2021 May;91:103098. doi: 10.1016/j.drugpo.2020.103098. Epub 2021 Jan 19.
6
Critical Care Network in the State of Qatar.卡塔尔国重症监护网络。
Qatar Med J. 2019 Nov 7;2019(2):2. doi: 10.5339/qmj.2019.qccc.2. eCollection 2019.
7
Blending research and practice: an evolving dissemination strategy in substance abuse.融合研究与实践:药物滥用领域中不断发展的传播策略。
Soc Work Public Health. 2013;28(3-4):302-12. doi: 10.1080/19371918.2013.774660.
8
Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).日落与整合,促进科学与治疗学的发展:国家药物滥用研究所(NISUD)。
Addiction. 2010 Dec;105(12):2044-9. doi: 10.1111/j.1360-0443.2010.03071.x.
9
Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.国家药物滥用研究所国家治疗临床试验网络中的性别研究:研究结果概述。
Am J Drug Alcohol Abuse. 2011 Sep;37(5):301-12. doi: 10.3109/00952990.2011.596875.
10

引用本文的文献

1
"Anything can happen": experiences of people using opioids in a xylazine market.“什么事情都可能发生”:在赛拉嗪市场使用阿片类药物者的经历
Harm Reduct J. 2025 Jul 31;22(1):134. doi: 10.1186/s12954-025-01275-z.
2
Pharmacovigilance-related events, disease burden and overall efficiency of care in european countries, 1990-2021.1990 - 2021年欧洲国家与药物警戒相关的事件、疾病负担及整体医疗效率
Front Pharmacol. 2025 Jun 27;16:1592957. doi: 10.3389/fphar.2025.1592957. eCollection 2025.
3
Co-design of the Australian Prompt Response Network for a public-health focused intersectoral approach to information sharing on emerging drugs of concern.澳大利亚快速反应网络的共同设计,采用以公共卫生为重点的跨部门方法,就新出现的关注药物进行信息共享。
Front Public Health. 2025 Jun 25;13:1521911. doi: 10.3389/fpubh.2025.1521911. eCollection 2025.
4
Syringe services program staff and participant perspectives on changing drug consumption behaviors in response to xylazine adulteration.注射器服务项目工作人员和参与者对因阿扎他啶掺假而改变药物使用行为的看法。
Harm Reduct J. 2024 Aug 30;21(1):162. doi: 10.1186/s12954-024-01082-y.
5
Protective or potentially harmful? Altering drug consumption behaviors in response to xylazine adulteration.具有保护作用还是潜在有害?应对赛拉嗪掺假而改变药物消费行为。
Res Sq. 2024 Aug 7:rs.3.rs-4810429. doi: 10.21203/rs.3.rs-4810429/v1.
6
Co-designing drug alerts for health and community workers for an emerging early warning system in Victoria, Australia.为澳大利亚维多利亚州新兴的早期预警系统共同设计针对卫生和社区工作者的药物警报。
Harm Reduct J. 2023 Mar 9;20(1):30. doi: 10.1186/s12954-023-00761-6.
7
'We don't live in a harm reduction world, we live in a prohibition world': tensions arising in the design of drug alerts.“我们生活在一个禁止毒品的世界,而不是一个减少伤害的世界”:药物警报设计中出现的紧张局势。
Harm Reduct J. 2023 Jan 9;20(1):3. doi: 10.1186/s12954-022-00716-3.
8
Changes in illicit drug use and markets with the COVID-19 pandemic and associated restrictions: findings from the Ecstasy and Related Drugs Reporting System, 2016-20.随着 COVID-19 大流行和相关限制措施的出现,非法药物使用和市场的变化:来自摇头丸及相关毒品报告系统的研究结果,2016-20 年。
Addiction. 2022 Jan;117(1):182-194. doi: 10.1111/add.15620. Epub 2021 Jul 16.
9
Nobody Wants to Be Narcan'd: A Pilot Qualitative Analysis of Drug Users' Perspectives on Naloxone.无人愿意接受纳洛酮注射:吸毒者对纳洛酮看法的初步定性分析
West J Emerg Med. 2021 Feb 8;22(2):339-345. doi: 10.5811/westjem.2020.10.48768.

本文引用的文献

1
Determining spatial access to opioid use disorder treatment and emergency medical services in New Hampshire.确定新罕布什尔州阿片类药物使用障碍治疗和紧急医疗服务的空间可及性。
J Subst Abuse Treat. 2019 Jun;101:55-66. doi: 10.1016/j.jsat.2019.03.013. Epub 2019 Apr 5.
2
Detecting Novel and Emerging Drug Terms Using Natural Language Processing: A Social Media Corpus Study.使用自然语言处理检测新型和新兴药物术语:一项社交媒体语料库研究。
JMIR Public Health Surveill. 2018 Jan 8;4(1):e2. doi: 10.2196/publichealth.7726.
3
Drug information systems, early warning, and new drug trends: can drug monitoring systems become more sensitive to emerging trends in drug consumption?药物信息系统、早期预警与新药趋势:药物监测系统能否对药物消费的新趋势变得更加敏感?
Subst Use Misuse. 2000 May-Jun;35(6-8):811-44. doi: 10.3109/10826080009148423.